Skip to main content

Table 1 Patient characteristics by occurrence of symptomatic cerebral vasospasm

From: Can admission lipoprotein-associated phospholipase A2 predict the symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage?

Characteristics

Total (n = 128)

SCV (n = 12)

No SCV (n = 116)

P value

Demographics

 Age, year

53.44 ± 10.51

55.00 ± 9.95

53.28 ± 10.59

0.590

 Gender, female

70 (54.69%)

7 (58.33%)

63 (54.31%)

0.790

Admission clinical grade

 WFNS grade

   

0.007

 Grade I

56 (43.75%)

1 (8.33%)

55 (47.41%)

 

 Grade II

6 (4.69%)

1 (8.33%)

5 (4.31%)

 

 Grade III

14 (10.94%)

2 (16.67%)

12 (10.34%)

 

 Grade IV

30 (23.44%)

3 (25.00%)

27 (23.28%)

 

 Grade V

22 (17.19%)

5 (41.67%)

17 (14.66%)

 

Admission blood pressure

 SAP, mmHg

146.36 ± 23.97

140.08 ± 25.50

147.01 ± 23.83

0.343

 DAP, mmHg

83.88 ± 11.70

81.42 ± 9.31

84.14 ± 11.92

0.445

 MAP, mmHg

104.71 ± 14.34

100.97 ± 13.99

105.09 ± 14.38

0.345

Admission CT scan grade

 Modified Fisher grade

2 (2–3)

2 (2–3)

4 (3–4)

< 0.001

Medical history

 Hypertension

57 (44.53%)

7 (58.33%)

50 (43.10%)

0.312

 Diabetes mellitus

16 (12.50%)

3 (25.00%)

13 (11.21%)

0.174

 Cardiovascular disease

19 (14.84%)

3 (25.00%)

16 (13.79%)

0.385

Smoking history

35 (27.34%)

4 (33.33%)

31 (26.72%)

0.735

Aneurysm characteristics

 Aneurysm size, mm

7.25 ± 4.24

8.75 ± 6.22

7.09 ± 3.99

0.197

 Multiple aneurysms

35 (27.34%)

3 (25.00%)

32 (27.59%)

1.000

 Anterior circulation

94 (73.44%)

9 (75.00%)

85 (73.28%)

1.000

 Clipping

109 (85.16%)

11 (91.67%)

98 (84.48%)

1.000

Laboratory

 Lp-PLA2, μg/L

182.09 ± 60.09

224.47 ± 76.14

177.70 ± 56.79

0.010

Medical complications

 Pneumonia

51 (39.84%)

8 (66.67%)

43 (37.07%)

0.063

 Intracranial infection

11 (8.59%)

1 (8.33%)

10 (8.62%)

1.000

 Sepsis

5 (3.91%)

1 (8.33%)

4 (3.45%)

0.394

 Hydrocephalus

18 (14.06%)

2 (16.67%)

16 (13.79%)

0.677

  1. Values are n (%), mean ± SD, median (25–75%)
  2. SCV symptomatic cerebral vasospasm, SAP systolic arterial pressure, DAP diastolic arterial pressure, MAP mean arterial pressure, Lp-PLA2 lipoprotein-associated phospholipase A2